viral infections Archives
COVID-19 battle begins in the nose
Feb. 2, 2023—A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.
Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections
Feb. 2, 2023— by Bill Snyder More than a million people in the United States are living with HIV, the virus that causes AIDS. One-fifth of them have been co-infected by the hepatitis C virus (HCV), which attacks the liver. Curative drugs for HCV are available, but many people don’t know they’ve been infected. And if they...
Probing innate immunity
May. 19, 2020—Manuel Ascano team validates an inhibitor of the cGAS-STING signaling pathway, which is important for cellular innate immunity against bacteria, viruses, and our own damaged DNA.
RSV-HRV viral interference
May. 15, 2017—RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.
Enzyme holds the door for influenza
Aug. 20, 2014—Compounds developed at Vanderbilt University may offer a new way to block influenza infection.
Neural receptor for reovirus
Jul. 18, 2014—A newly identified receptor allows mammalian reovirus to infect neurons, shedding light on factors important for viral encephalitis.
Target cell entry to halt Chikungunya virus
Apr. 28, 2014—Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications.
Multi-center effort targets lethal Ebola, Marburg viruses
Mar. 6, 2014—Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections.
